EUCTR2011-005822-23-SE进行中（未招募）1 期
CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA
Haukeland University Hospital0 个研究点目标入组 20 人开始时间: 2013年9月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients with verified salt-wasting CAH and simple virilising CAH
- •- Age 18-60
- •- On single prednisone, or hydrocortisone treatment
- •- Written informed consent
- •- In case of concomitant endocrine/autoimmune diseases, should be on stable treatment during the study period
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Patients with diabetes mellitus
- •- Cardiovascular disease (Myocardial infarction or angina pectoris within the last 2 years, moderate to severe heart failure)
- •- Active malignant disease
- •- Pregnancy or breast feeding
- •- Pharmacological treatment with glucocorticoids or drugs that induces liver enzymes (antiepileptics, rifampicin, St. Johns wart)
- •- Intake of grapefruit juice (that inhibits CYP3A4) the last two weeks before or during the study period
研究者
相似试验
进行中（未招募）
不适用
A trial comparing continuous subcutaneous hydrocortisone therapy with conventional oral glucocorticoid therapy in congenital adrenal hyperplasiaCongenital adrenal hyperplasia (CAH)MedDRA version: 14.1Level: LLTClassification code 10010323Term: Congenital adrenal hyperplasiaSystem Organ Class: 100000004850EUCTR2011-005822-23-NOHaukeland University Hospital
进行中（未招募）
不适用
A trial comparing continuous subcutaneous hydrocortisone therapy with pulsatile subcutaneous hydrocortisone therapy in patients with Addison`s diseaseEUCTR2013-004189-33-NOHaukeland University Hospital10
已完成
不适用
How are repeat(ed) steroid injections into osteoarthritic joints used and what are the outcomes?OsteoarthritisISRCTN32433800niversity of Bristol148
招募中
不适用
Prevention of antivenom reactions by administering intravenous hydrocortosne 2 hours before antivenom treatmentSnake bite,antivenom reactionsSLCTR/2010/005Prof SAM Kularatne
已完成
不适用
Continuous subcutaneous injection of octreotide for congtenital hyperinsulinism: efficacy and safety.congenital hyperinsulinismJPRN-UMIN000012620Japan Agency for Medical Research and Development. Research group for the study on "Efficacy and safety of subcutaneous continuous octreotide infusion for congenital hyperinsulinism."7